Excluding individuals with a personal or family history of Lynch syndrome (2.5% of the total population), nearly 9% of the eligible study participants had a loss of MMR protein expression, of which two-thirds had either BRAF mutation or MLH1 promoter hypermethylation (Supplementary Figure S1), suggesting somatic rather than germline mutation of the MMR genes. Here, MLH1 is linked to Lynch syndrome.